Skip to Main Content

As new technologies help scientists automate and miniaturize experiments, companies are getting better at streamlining the drug discovery process. This week brought two new examples.

In one study, published Thursday in the journal Science, researchers at Pfizer described a new system that allows chemists to run thousands of reactions much faster than they could previously to determine the best way to produce the greatest amount of desired compounds.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.